These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 1321554)

  • 1. Stereospecific and non-stereospecific effects of ibuprofen on human platelet and polymorphonuclear leukocyte functions.
    Villanueva M; Heckenberger R; Palmér M; Schrör K
    Agents Actions Suppl; 1992; 37():162-70. PubMed ID: 1321554
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Equipotent inhibition by R(-)-, S(+)- and racemic ibuprofen of human polymorphonuclear cell function in vitro.
    Villanueva M; Heckenberger R; Strobach H; Palmér M; Schrör K
    Br J Clin Pharmacol; 1993 Mar; 35(3):235-42. PubMed ID: 8385973
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of human platelets and polymorphonuclear neutrophils by the potent and metabolically stable prostaglandin D2 analog ZK 118.182.
    Darius H; Michael-Hepp J; Thierauch KH; Fisch A
    Eur J Pharmacol; 1994 Jun; 258(3):207-13. PubMed ID: 7522176
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyclooxygenase inhibitors and the antiplatelet effects of aspirin.
    Catella-Lawson F; Reilly MP; Kapoor SC; Cucchiara AJ; DeMarco S; Tournier B; Vyas SN; FitzGerald GA
    N Engl J Med; 2001 Dec; 345(25):1809-17. PubMed ID: 11752357
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of ibuprofen enantiomers and its coenzyme A thioesters on human prostaglandin endoperoxide synthases.
    Neupert W; Brugger R; Euchenhofer C; Brune K; Geisslinger G
    Br J Pharmacol; 1997 Oct; 122(3):487-92. PubMed ID: 9351505
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interference of anti-inflammatory and anti-asthmatic drugs with neutrophil-mediated platelet activation: singularity of azelastine.
    Renesto P; Balloy V; Vargaftig BB; Chignard M
    Br J Pharmacol; 1991 Jun; 103(2):1435-40. PubMed ID: 1653073
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of dexibuprofen on platelet function in humans: comparison with low-dose aspirin.
    González-Correa JA; Arrebola MM; Martín-Salido E; Muñoz-Marín J; de la Cuesta FS; De La Cruz JP
    Anesthesiology; 2007 Feb; 106(2):218-25. PubMed ID: 17264714
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of a nonsteroidal anti-inflammatory agent, ibuprofen, in coronary revascularization after acute myocardial infarction.
    Clement R; Das DK; Engelman RM; Otani H; Bandhyopadhyay D; Hoory S; Antar M; Rousou JA; Breyer RH; Prasad MR
    Basic Res Cardiol; 1990; 85(1):55-70. PubMed ID: 2109599
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of racemic ibuprofen dose on the magnitude and duration of platelet cyclo-oxygenase inhibition: relationship between inhibition of thromboxane production and the plasma unbound concentration of S(+)-ibuprofen.
    Evans AM; Nation RL; Sansom LN; Bochner F; Somogyi AA
    Br J Clin Pharmacol; 1991 Feb; 31(2):131-8. PubMed ID: 1904749
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent FDA warning of the concomitant use of aspirin and ibuprofen and the effects on platelet aggregation.
    Ellison J; Dager W
    Prev Cardiol; 2007; 10(2):61-3. PubMed ID: 17392619
    [No Abstract]   [Full Text] [Related]  

  • 11. Hydroxychavicol, a novel betel leaf component, inhibits platelet aggregation by suppression of cyclooxygenase, thromboxane production and calcium mobilization.
    Chang MC; Uang BJ; Tsai CY; Wu HL; Lin BR; Lee CS; Chen YJ; Chang CH; Tsai YL; Kao CJ; Jeng JH
    Br J Pharmacol; 2007 Sep; 152(1):73-82. PubMed ID: 17641677
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis of 2-alkoxy 1,4-naphthoquinone derivatives as antiplatelet, antiinflammatory, and antiallergic agents.
    Lien JC; Huang LJ; Teng CM; Wang JP; Kuo SC
    Chem Pharm Bull (Tokyo); 2002 May; 50(5):672-4. PubMed ID: 12036028
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Platelet adhesivity to subendothelium is influenced by polymorphonuclear leukocytes: studies with aspirin and salicylate.
    Hernández R; Alemany M; Bozzo J; Buchanan MR; Ordinas A; Bastida E
    Haemostasis; 1993; 23(1):1-7. PubMed ID: 8477903
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differences in the in vitro antiplatelet effect of dexibuprofen, ibuprofen, and flurbiprofen in human blood.
    De la Cruz JP; Reyes JJ; Ruiz-Moreno MI; Lopez-Villodres JA; Jebrouni N; Gonzalez-Correa JA
    Anesth Analg; 2010 Dec; 111(6):1341-6. PubMed ID: 21048099
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduction of polymorphonuclear leukocyte accumulations by inhibition of cyclooxygenase and thromboxane syntase in the rabbit.
    Palder SB; Huval W; Lelcuk S; Alexander F; Shepro D; Mannick JA; Hechtman HB
    Surgery; 1986 Jan; 99(1):72-81. PubMed ID: 3079930
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Licofelone, a dual lipoxygenase-cyclooxygenase inhibitor, downregulates polymorphonuclear leukocyte and platelet function.
    Rotondo S; Dell'Elba G; Krauze-Brzósko K; Manarini S; Martelli N; Pecce R; Evangelista V; Cerletti C
    Eur J Pharmacol; 2002 Oct; 453(1):131-9. PubMed ID: 12393068
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of novel antifungal azole derivatives on the 5-lipoxygenase and cyclooxygenase pathway.
    Steinhilber D; Jaschonek K; Knospe J; Morof O; Roth HJ
    Arzneimittelforschung; 1990 Nov; 40(11):1260-3. PubMed ID: 2128178
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diffusion of peroxynitrite into the human platelet inhibits cyclooxygenase via nitration of tyrosine residues.
    Boulos C; Jiang H; Balazy M
    J Pharmacol Exp Ther; 2000 Apr; 293(1):222-9. PubMed ID: 10734173
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential inhibition of human platelet aggregation and thromboxane A2 formation by L-arginine in vivo and in vitro.
    Bode-Böger SM; Böger RH; Galland A; Frölich JC
    Naunyn Schmiedebergs Arch Pharmacol; 1998 Feb; 357(2):143-50. PubMed ID: 9521487
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MK 287: a potent, specific, and orally active receptor antagonist of platelet-activating factor.
    Hwang SB; Lam MH; Szalkowski DM; MacIntyre DE; Bach TJ; Luell S; Meuer R; Sahoo SP; Alberts AW; Chabala JC
    J Lipid Mediat; 1993 Jun; 7(2):115-34. PubMed ID: 8400114
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.